| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.44 | 0.0009 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.42 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.42 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.32 | 2e-11 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.3 | 1e-09 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.29 | 6e-13 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.29 | 8e-10 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.26 | 0.0007 |